5HT2A antagonist to combat fatty liver diseaseMetabolic dysfunction-associated steatotic liver disease (MASLD) is a burgeoning global health concern, posing a significant threat to...
Tirzepatide found to reduce body weight regardless of duration of condition and BMI before treatment18 hours ago